Bepridil monotherapy failed to prevent coronary vasospasm in a Brugada syndrome patient

Coronary vasospasm sometimes coexists with Brugada syndrome (BrS) and is reportedly associated with poor prognosis. Although calcium channel blockers are considered first-line drugs to prevent coronary vasospasm, they also have the potential to induce ST elevation and ventricular fibrillation (VF) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazatani, Takuro, Higaki, Akinori, Tanaka, Yuta, Kawada, Yoshitaka, Hiasa, Go, Yamada, Tadakatsu, Okayama, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389561/
https://www.ncbi.nlm.nih.gov/pubmed/35991495
http://dx.doi.org/10.1093/omcr/omac082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389561/
https://www.ncbi.nlm.nih.gov/pubmed/35991495
http://dx.doi.org/10.1093/omcr/omac082

Ejemplares similares